Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Gilead Sciences Inc. Stories

2010-07-13 09:00:00

VANCOUVER, Canada, July 13 /PRNewswire-Asia/ -- Today Insiderslab.com issues new research reports on large insider trades found in the above Blue Chips or Penny Stock companies. Insiders refer to company C-Level Officers (CEOs, CFOs, COOs) and Directors who are involved in making critical corporate decisions. There are thousands of insider filings on the stock markets every day. Insiderslab.com strives to turn this massive raw data into usable information that investors can use to do...

2010-06-21 09:00:00

VANCOUVER, Canada, June 21 /PRNewswire-Asia/ -- Today Insiderslab.com issues new research reports for the above companies in NASDAQ and NYSE. Insiders refer to company C-Level Officers, Directors, and 10% Shareholders. There are thousands of insider filings on the stock markets every day. Insiderslab.com's primary objective is to turn this massive data into usable information that investors can use to do better research for their investments. (Logo:...

2010-05-27 08:31:00

CHICAGO, May 27 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for MCD, GILD, TOT, NTAP, and TXT. Seven Summits Strategic Investments' PriceWatch Alerts are available at http://www.iotogo.com/s/052710A (Note: You may have to copy this link into your browser then press the [ENTER] key.) Today's PriceWatch Alerts cover the following stocks: McDonald's Corp. (NYSE: MCD), Gilead Sciences Inc. (Nasdaq: GILD), Total SA (NYSE: TOT), NetApp, Inc. (Nasdaq: NTAP), and Textron Inc....

2010-02-22 20:48:00

CF Foundation's $1 Million Investment Helped Drug Known as Cayston(R) Become a Reality BETHESDA, Md., Feb. 22 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration approved an important new inhaled antibiotic called Cayston® (aztreonam for inhalation solution) today for the treatment of cystic fibrosis. The drug was made possible by significant support from the Cystic Fibrosis Foundation, including a $1 million investment by a Foundation subsidiary to help...

2010-02-17 08:31:00

CHICAGO, Feb. 17 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for XOM, GILD, EQR, DLTR, and IVZ. Seven Summits Strategic Investments' PriceWatch Alerts are available at http://www.iotogo.com/s/021710A (Note: You may have to copy this link into your browser then press the [ENTER] key.) Today's PriceWatch Alerts cover the following stocks: ExxonMobil Corp. (NYSE: XOM), Gilead Sciences Inc. (Nasdaq: GILD), Equity Residential (NYSE: EQR), Dollar Tree, Inc. (Nasdaq: DLTR),...

2010-01-20 08:31:00

CHICAGO, Jan. 20 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for AIG, PG, GILD, TMO, and AZN. Seven Summits Strategic Investments' PriceWatch Alerts are available at http://www.iotogo.com/s/012010A (Note: You may have to copy this link into your browser then press the [ENTER] key.) Today's PriceWatch Alerts cover the following stocks: American International Group, Inc. (NYSE: AIG), Procter & Gamble Co. (NYSE: PG), Gilead Sciences Inc. (Nasdaq: GILD), Thermo Fisher...

2009-11-23 07:00:00

REDWOOD CITY, Calif., Nov. 23 /PRNewswire/ -- Pearl Therapeutics Inc., a biopharmaceutical company developing therapeutic products for the treatment of chronic respiratory diseases, today announced the appointment of Howie Rosen to the company's Board of Directors. Mr. Rosen has 25 years of experience in the pharmaceutical and biotechnology industries, including key roles at Gilead Sciences and ALZA Corporation. His appointment increases the number of directors on Pearl's Board to six....

2009-10-06 09:26:00

NEW YORK, Oct. 6 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile http://www.reportlinker.com/p0151769/Reportlinker-Adds-Gilead-Sciences-Inc-PharmaVitae-Profile.html Introduction This analysis examines the historical and forecast performance for Gilead in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and...

2009-07-16 15:28:00

CORK, Ireland, July 16 /PRNewswire/ --Tibotec Pharmaceuticals today announced that it has entered into a license and collaboration agreement with Gilead Sciences, Inc. for the development and commercialization of a new once-daily fixed-dose antiretroviral product containing Tibotec's investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) TMC278 (rilpivirine hydrochloride 25 mg) and Gilead's Truvada (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) for...

2009-07-02 13:37:00

SUNNYVALE, Calif., July 2 /PRNewswire/ -- Advanced Chemical Transport, one of the leading environmental companies in California, has announced a multi-year partnership with Gilead Sciences Inc., North America's third largest Bio-Med company. ACT will provide Environmental services - including hazardous Materials disposal, vacuum truck services, spill response, site specific services and onsite waste management support from its corporate headquarters in Sunnyvale, CA. ACT has experienced...